Tien Liang BioTech Co., Ltd.
Research Tien Liang BioTech Co., Ltd. (4127.TWO) on Bullrun: market cap TWD 1.83B, P/E 26.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4127.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 1.83B
- P/E26.3
- Financial periodQ2 2026
- RevenueTWD 184.74M
- Net incomeTWD 14.15M
- Free cash flowTWD 26.32M
- Gross margin60.6%
Valuation Snapshot
latest market cap is TWD 1.83B; P/E is 26.3.
Peer valuation comparison
Latest P/E is 26.35x versus a Healthcare sector median of 21.8x (20.9% above).
Latest P/E is 26.35x versus a Taiwan median of 18.67x (41.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.83B | 26.3 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Tien Liang BioTech Co., Ltd.
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tien Liang BioTech Co., Ltd.'s market cap?
Tien Liang BioTech Co., Ltd.'s market capitalization is TWD 1.83B.
What is Tien Liang BioTech Co., Ltd.'s P/E ratio?
Tien Liang BioTech Co., Ltd.'s price-to-earnings (P/E) ratio is 26.3.
What does Tien Liang BioTech Co., Ltd. do?
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.